trending Market Intelligence /marketintelligence/en/news-insights/trending/aVfAw-6Pe9ucmYg2BiXp9g2 content esgSubNav
In This List

Collegium Pharmaceutical appoints director

Blog

Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet


Collegium Pharmaceutical appoints director

Collegium Pharmaceutical Inc. appointed Gwen Melincoff as a class III director, effective Aug. 9, with an initial term expiring at the next annual meeting of shareholders in 2018.

Melincoff is currently managing director at Gemini Advisors LLC and an adviser to Phase 1 Ventures and Verge Genomics.